World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
79
Citations
24415
World Ranking
1206
National Ranking
61

Medicine

D-Index
82
Citations
28602
World Ranking
15974
National Ranking
604

Overview

Martin P. Grobusch is affiliated with the University of Amsterdam in the Netherlands. Their research primarily spans the field of medicine, with extensive work in several subfields including Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Parasitology, and Pediatrics, Perinatology, and Child Health.

Their work covers a range of main topics, including:

  • Travel-related health issues
  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • Viral Infections and Outbreaks Research
  • Parasites and Host Interactions
  • Tuberculosis Research and Epidemiology
  • Viral Infections and Vectors

Frequent co-authors in their research include Abraham Goorhuis, Ayôla Akim Adégnika, Diederik van de Beek, Cornelis Stijnis, and Bayodé Roméo Adégbitè.

Martin P. Grobusch has published extensively in several scientific venues, with a notable number of publications in:

  • Travel Medicine and Infectious Disease
  • Journal of Travel Medicine
  • Flugmedizin · Tropenmedizin · Reisemedizin - FTR
  • New Microbes and New Infections
  • The Lancet Infectious Diseases

Among their recent papers are the following:

  • "Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity," 2020, Science
  • "Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial," 2020, The Lancet
  • "Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history," 2021, Microbial Genomics
  • "Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial," 2021, The Lancet Infectious Diseases
  • "Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study," 2022, The Lancet Infectious Diseases

Best Publications

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • The diarylquinoline TMC207 for multidrug-resistant tuberculosis

    Andreas H Diacon;Alexander Pym;Martin Grobusch;Ramonde Patientia

  • Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

    Andreas H. Diacon;Alexander Pym;Martin P. Grobusch;Jorge M. de los Rios

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study

    Maris S Arcilla;Jarne M van Hattem;Manon R Haverkate;Martin C J Bootsma;Martin C J Bootsma

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    A. H. Diacon;P. R. Donald;A. Pym;M. Grobusch

  • Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

    John J Aponte;David Schellenberg;Andrea Egan;Alasdair Breckenridge

  • Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

    Keertan Dheda;Keertan Dheda;Karen Shean;Alimuddin Zumla;Motasim Badri

  • High recombination rate in natural populations of Plasmodium falciparum

    David J. Conway;Cally Roper;Ayoade M. J. Oduola;David E. Arnot

  • Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation

    Patricia Schlagenhauf;Leisa Weld;Abraham Goorhuis;Philippe Gautret

  • Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases.

    T. Jelinek;C. Schulte;R. Behrens;M. P. Grobusch

  • Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.

    Rob W van der Pluijm;Rob W van der Pluijm;Rob W van der Pluijm;Rupam Tripura;Rupam Tripura;Richard M Hoglund;Richard M Hoglund;Aung Pyae Phyo

  • Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction.

    Sébastien Matamoros;Jarne M van Hattem;Maris S Arcilla;Niels Willemse

  • Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

    Ruth McNerney;Markus Maeurer;Ibrahim Abubakar;Ibrahim Abubakar;Ben Marais

  • How useful is PCR in the diagnosis of malaria

    Thomas Hänscheid;Martin P. Grobusch

  • Long-term sequelae of chikungunya virus disease: A systematic review.

    Mariëlle van Aalst;Charlotte Marieke Nelen;Abraham Goorhuis;Cornelis Stijnis

  • Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.

    Katja Steinhagen;Christian Probst;Christiane Radzimski;Jonas Schmidt-Chanasit

  • Assessing the consequences of stigma for tuberculosis patients in urban Zambia.

    Anne Lia Cremers;Myrthe Manon de Laat;Nathan Kapata;Rene Gerrets

  • Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs

    Alimuddin Zumla;Ibrahim Abubakar;Mario Raviglione;Michael Hoelscher

  • Biological warfare, bioterrorism, and biocrime.

    Hugo J. Jansen;Florence J. Breeveld;Cornelis Stijnis;Martin P. Grobusch

  • Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop

    T. Jelinek;N. Mühlberger;G. Harms;M. Corachán

Frequent Co-Authors

Peter G. Kremsner
Peter G. Kremsner University of Tübingen
Abraham Goorhuis
Abraham Goorhuis University of Amsterdam
Bertrand Lell
Bertrand Lell University of Tübingen
Ayola A. Adegnika
Ayola A. Adegnika University of Tübingen
Saadou Issifou
Saadou Issifou University of Tübingen
Frieder Schaumburg
Frieder Schaumburg University of Münster
Benjamin Mordmüller
Benjamin Mordmüller Radboud University Medical Center
Alimuddin Zumla
Alimuddin Zumla University College London
Frank P. Mockenhaupt
Frank P. Mockenhaupt Charité - University Medicine Berlin
Tom van der Poll
Tom van der Poll University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open diverse career opportunities. Many students consider certifications that complement their scientific background, such as an online medical billing and coding certificate fast. This path offers a quick entry into healthcare administration, providing stability alongside scientific roles.

Additionally, a variety of medical programs online make it easier for microbiology graduates to pivot into clinical or research-related medical fields without relocating, ensuring flexible study options tailored to busy lifestyles.

For those drawn to public health, easy MPH online programs to get into provide a manageable way to build expertise in epidemiology and health policy, areas closely linked to microbiology.

Finally, innovative career paths like becoming a child life specialist are gaining attention. Understanding the emotional and developmental needs of children benefits greatly from a scientific foundation. Discover details on the certified child life specialist salary and career outlook to see if this is the right fit for you.

Best Scientists Citing Martin P. Grobusch

Trending Scientists

Recently Published Articles